<?xml version="1.0" encoding="UTF-8"?>
<ref id="R35">
 <label>35.</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Savona</surname>
   <given-names>MR</given-names>
  </name>, 
  <name>
   <surname>Kolibaba</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Conkling</surname>
   <given-names>P</given-names>
  </name>, 
  <etal/>
  <article-title>CC-486 in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), or chronic myelomonocytic leukemia (CMML): safety, tolerability, and response</article-title>. 
  <source>Blood (ASH Annual Meeting Abstracts)</source>. 
  <year>2014</year>;
  <volume>124</volume>. 
  <comment>Abstract 4638.</comment>
 </mixed-citation>
</ref>
